WEBHELP
10.5.2022 14:27:13 CEST | Business Wire | Press release
Webhelp , a leading global provider of customer experience (CX) and business solutions, announced it has been named a Star Performer by leading global analyst firm Everest Group in its Trust and Safety – Content Moderation Services PEAK Matrix® Assessment 2022 . Everest Group selects Star Performers based on YoY improvement on the PEAK Matrix; Webhelp was one of only two providers awarded this status.
“Webhelp, being experienced in addressing the trust and safety needs of buyers across all industries, has recently expanded its client portfolio significantly and enhanced its suite of services offered to clients,” said Abhijnan Dasgupta , Practice Director, Everest Group. “Webhelp has expanded its delivery presence in LATAM, EMEA, and APAC and has invested in augmenting its proprietary tools (such as Proteus and Moderatus), which are leveraged by moderators for non-egregious content moderation. These are some of the factors that have contributed to Webhelp strengthening its positioning as a Major Contender and being recognized as a Star Performer in Everest Group’s Trust and Safety – Content Moderation Services PEAK Matrix® 2022.”
The report validates Webhelp’s strength in multilingual support in its trust and safety practice, including the use of its proprietary translation technologies, helping deliver consistent, multilingual experiences at scale. This coupled with Webhelp’s design and consulting capabilities, enables the business to build consistent and safe user experiences.
“We are very proud of our assessment and recognition as a Star Performer by Everest Group, validating the growth of our global Trust and Safety practice,” said Chloé de Mont-Serrat, Webhelp’s Co-CEO of Digital Content Services. “Whether a business is digital native or looking to transform and increase its online presence, trust and safety has become vital across industries. We support some of the leading brands, so we’ve invested heavily in moderation platforms, ensuring our clients’ safety and reputation.”
“The information landscape is continuing to change rapidly, and it’s important we are involved in this conversation to inform and advise our clients. We’re proud to have recently joined the Trust & Safety Professional Association and will continue to implement industry knowledge and best practices across our global team,” said Paul Danter, Co-CEO of Digital Content Services, Webhelp.
Everest Group’s “Trust and Safety – Content Moderation Services, PEAK Matrix® Assessment 2022” evaluated 18 providers, positioning them on a comprehensive set of quantitative and qualitative criteria based on their vision & capability, and market impact.
This announcement follows a series of accolades from top industry analysts, with Webhelp being positioned as a Leader in the 2022 Gartner Magic Quadrant for Customer Service BPO . Additionally, Webhelp was named the most innovative CX provider in Frost and Sullivan’s 2021 Frost Radar™ report .
- END -
About Webhelp
Webhelp designs, delivers, and optimizes unforgettable human experiences for today’s digital world – creating game-changing customer journeys. From sales to service, content moderation to credit management, Webhelp is an end-to-end partner across all B2C and B2B customer journeys. Its over 100,000 passionate employees across more than 55 countries thrive on making a difference for the world’s most exciting brands. Webhelp is currently owned by its management and Groupe Bruxelles Lambert (Euronext: GBLB), a leading global investment holding, as of November 2019.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510005878/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom